Suggested Dosing of Select Beta-lactam Agents for the Treatment of Antimicrobial-Resistant Gram-Negative Infections in Children
Journal of the Pediatric Infectious Diseases Society · 06.02.2025 · 14 (2)
DOI: 10.1093/jpids/piaf004 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of the Pediatric Infectious Diseases Society, online erschienen am 23.01.2025. Verfasst von Christine R Lockowitz und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, St. Louis Children's Hospital, St. Louis, MO, United States. Hauptthemen laut MEDLINE: Gram-Negative Bacterial Infections, Anti-Bacterial Agents, beta-Lactams. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 119 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
The Infectious Diseases Society of America (IDSA) publishes annual guidance on the treatment of antimicrobial-resistant (AMR) gram-negative infections. Within the AMR guidance, suggested dosages of antibiotics for adults infected with AMR pathogens are provided. This document serves as a companion document to the IDSA guidance to assist pediatric specialists with dosing β-lactam agents for the treatment of AMR infections in children. A panel of 13 pediatric infectious diseases specialists, including 11 pharmacists and 2 physicians, reviewed existing pharmacokinetic/pharmacodynamic, animal, and clinical data for newer β-lactam agents that are available in the United States and suggested for the treatment of AMR infections (ie, cefiderocol, ceftazidime-avibactam, ceftazidime-avibactam and aztreonam, ceftolozane-tazobactam, imipenem-cilastatin-relebactam, meropenem-vaborbactam, sulbactam-durlobactam). Suggested dosing for ampicillin-sulbactam is also provided, given complexities in dosing for carbapenem-resistant Acinetobacter baumannii infections. Consensus-based suggested dosing for β-lactam agents used to treat AMR infections in neonates, infants, children, and adolescents and relevant supporting evidence are provided. Content is up to date as of December 1, 2024. Gaps and limitations to existing data are discussed. Optimizing antibiotic dosing is critical to improving the outcomes of children with AMR infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, St. Louis Children's Hospital, St. Louis, MO, United States.
- Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
- Department of Pharmacy, The Johns Hopkins Hospital, Baltimore, MD, United States.
- Divisions of Critical Care Medicine and Infectious Diseases, Children's Hospital of Philadelphia, Philadelphia, PA, United States.
- Department of Anesthesia and Critical Care Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
- Department of Pharmacy, Lucile Packard Children's Hospital Stanford, Palo Alto, CA, United States.
ORCID-Profile: Laura L Bio, Grant Stimes, Pranita D Tamma
Zitieren
APA
Lockowitz, C. R., Hsu, A. J., Chiotos, K., Bio, L. L., Dassner, A. M., Gainey, A. B., Girotto, J. E., Iacono, D., Morrisette, T., Stimes, G., Tran, M. T., Wilson, W. S., & Tamma, P. D. (2025). Suggested Dosing of Select Beta-lactam Agents for the Treatment of Antimicrobial-Resistant Gram-Negative Infections in Children. Journal of the Pediatric Infectious Diseases Society, 14(2). https://doi.org/10.1093/jpids/piaf004
Vancouver
Lockowitz CR, Hsu AJ, Chiotos K, Bio LL, Dassner AM, Gainey AB, et al. Suggested Dosing of Select Beta-lactam Agents for the Treatment of Antimicrobial-Resistant Gram-Negative Infections in Children. Journal of the Pediatric Infectious Diseases Society. 2025;14(2). doi:10.1093/jpids/piaf004
BibTeX
@article{Lockowitz2025,
author = {Lockowitz, Christine R and Hsu, Alice J and Chiotos, Kathleen and Bio, Laura L and Dassner, Aimee M and Gainey, Andrew B and Girotto, Jennifer E and Iacono, Denise and Morrisette, Taylor and Stimes, Grant and Tran, M Tuan and Wilson, William S and Tamma, Pranita D},
title = {Suggested Dosing of Select Beta-lactam Agents for the Treatment of Antimicrobial-Resistant Gram-Negative Infections in Children},
journal = {Journal of the Pediatric Infectious Diseases Society},
year = {2025},
volume = {14},
number = {2},
doi = {10.1093/jpids/piaf004}
}
EUVIMED